117 related articles for article (PubMed ID: 31080677)
1. Desmoplastic Melanoma Arising after 1,064 nm q-Switched Nd:YAG Laser of a Suspected Solar Lentigo.
Cohen L; Nanda S; Zaiac M
Case Rep Dermatol Med; 2019; 2019():3907671. PubMed ID: 31080677
[TBL] [Abstract][Full Text] [Related]
2. Beneficial Effect of Low Fluence 1,064 nm Q-Switched Neodymium:Yttrium-Aluminum-Garnet Laser in the Treatment of Senile Lentigo.
Nam JH; Kim HS; Lee GY; Kim WS
Ann Dermatol; 2017 Aug; 29(4):427-432. PubMed ID: 28761290
[TBL] [Abstract][Full Text] [Related]
3. A Randomized Controlled Trial on the Effectiveness of Epidermal Growth Factor-Containing Ointment on the Treatment of Solar Lentigines as Adjuvant Therapy.
Kim HO; Kim HR; Kim JC; Kang SY; Jung MJ; Chang SE; Park CW; Chung BY
Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33668564
[No Abstract] [Full Text] [Related]
4. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
[TBL] [Abstract][Full Text] [Related]
5. An in vivo trial comparing the use of different types of 532 nm Nd:YAG lasers in the treatment of facial lentigines in Oriental patients.
Chan HH; Fung WK; Ying SY; Kono T
Dermatol Surg; 2000 Aug; 26(8):743-9. PubMed ID: 10940060
[TBL] [Abstract][Full Text] [Related]
6. Intradermal tranexamic acid injections to prevent post-inflammatory hyperpigmentation after solar lentigo removal with a Q-switched 532-nm Nd:YAG laser.
Sirithanabadeekul P; Srieakpanit R
J Cosmet Laser Ther; 2018; 20(7-8):398-404. PubMed ID: 29505310
[No Abstract] [Full Text] [Related]
7. Q-Switched 660-nm Versus 532-nm Nd: YAG Laser for the Treatment for Facial Lentigines in Asian Patients: A Prospective, Randomized, Double-Blinded, Split-Face Comparison Pilot Study.
Noh TK; Chung BY; Yeo UC; Chang S; Lee MW; Chang SE
Dermatol Surg; 2015 Dec; 41(12):1389-95. PubMed ID: 26551773
[TBL] [Abstract][Full Text] [Related]
8. Q-switched double frequency Nd:YAG 532-nm nanosecond laser vs. double frequency Nd:YAG 532-nm picosecond laser for the treatment of solar lentigines in Asians.
Vachiramon V; Iamsumang W; Triyangkulsri K
Lasers Med Sci; 2018 Dec; 33(9):1941-1947. PubMed ID: 29948457
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the frequency-doubled Q-switched Nd:YAG laser and 35% trichloroacetic acid for the treatment of face lentigines.
Li YT; Yang KC
Dermatol Surg; 1999 Mar; 25(3):202-4. PubMed ID: 10193967
[TBL] [Abstract][Full Text] [Related]
10. A split-face, evaluator-blind randomized study on the early effects of Q-switched Nd:YAG laser plus Er:YAG micropeel (combined therapy) versus Q-switched Nd:YAG alone in light solar lentigines in Asians.
Jun HJ; Cho SH; Lee JD; Kim HS
Lasers Med Sci; 2014 May; 29(3):1153-8. PubMed ID: 24292155
[TBL] [Abstract][Full Text] [Related]
11. A prospective, randomized, double-blinded, split-face pilot study comparing Q-switched 1064-nm Nd:YAG versus 532-nm Nd:YAG laser for the treatment of solar lentigines.
Bohnert K; Dorizas A; Sadick N
J Cosmet Laser Ther; 2018; 20(7-8):395-397. PubMed ID: 29482397
[TBL] [Abstract][Full Text] [Related]
12. In vivo trial comparing patients' tolerance of Q-switched Alexandrite (QS Alex) and Q-switched neodymium:yttrium-aluminum-garnet (QS Nd:YAG) lasers in the treatment of nevus of Ota.
Chan HH; King WW; Chan ES; Mok CO; Ho WS; Van Krevel C; Lau WY
Lasers Surg Med; 1999; 24(1):24-8. PubMed ID: 10037348
[TBL] [Abstract][Full Text] [Related]
13. Low-fluence Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser for the treatment of facial partial unilateral lentiginosis in Koreans.
Lee Y; Choi EH; Lee SW
Dermatol Surg; 2012 Jan; 38(1):31-7. PubMed ID: 22093176
[TBL] [Abstract][Full Text] [Related]
14. A split-face, evaluator-blind randomized study on the early effects of Q-switched Nd:YAG laser versus Er:YAG micropeel in light solar lentigines in Asians.
Jun HJ; Kim SM; Choi WJ; Cho SH; Lee JD; Kim HS
J Cosmet Laser Ther; 2014 Apr; 16(2):83-8. PubMed ID: 24409833
[TBL] [Abstract][Full Text] [Related]
15. The removal of cutaneous pigmented lesions with the Q-switched ruby laser and the Q-switched neodymium: yttrium-aluminum-garnet laser. A comparative study.
Tse Y; Levine VJ; McClain SA; Ashinoff R
J Dermatol Surg Oncol; 1994 Dec; 20(12):795-800. PubMed ID: 7798410
[TBL] [Abstract][Full Text] [Related]
16. A Case of Facial Partial Unilateral Lentiginosis Treated with Low-Fluence 1,064 nm Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser.
Kim EH
Case Rep Dermatol; 2017; 9(2):30-34. PubMed ID: 28690515
[TBL] [Abstract][Full Text] [Related]
17. A Prospective Randomized Controlled Study of Oral Tranexamic Acid for the Prevention of Postinflammatory Hyperpigmentation After Q-Switched 532-nm Nd:YAG Laser for Solar Lentigines.
Rutnin S; Pruettivorawongse D; Thadanipon K; Vachiramon V
Lasers Surg Med; 2019 Dec; 51(10):850-858. PubMed ID: 31302943
[TBL] [Abstract][Full Text] [Related]
18. A comparison of 3 lasers and liquid nitrogen in the treatment of solar lentigines: a randomized, controlled, comparative trial.
Todd MM; Rallis TM; Gerwels JW; Hata TR
Arch Dermatol; 2000 Jul; 136(7):841-6. PubMed ID: 10890985
[TBL] [Abstract][Full Text] [Related]
19. A randomized, split-face clinical trial of Q-switched alexandrite laser versus Q-switched Nd:YAG laser in the treatment of bilateral nevus of Ota.
Wen X; Li Y; Jiang X
J Cosmet Laser Ther; 2016; 18(1):12-5. PubMed ID: 25968166
[TBL] [Abstract][Full Text] [Related]
20. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study.
Lee MC; Chang CS; Huang YL; Chang SL; Chang CH; Lin YF; Hu S
Lasers Med Sci; 2015 Jan; 30(1):159-63. PubMed ID: 25073866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
